Amazon Pharmacy Offers Weight-Loss Drugs for $50 a Month to Medicare Patients

Product / Tech
โดย Yahoo Finance·US·Read original
Summary · why it matters

Amazon Pharmacy will offer eligible Medicare beneficiaries weight-loss drugs for $50 per month through a new federal bridge program. The service automates eligibility checks, prior authorizations, and billing, with home delivery and in-store pickup available. Most patients in its Bridge Program received prior authorization decisions in under 24 hours, faster than the 72-hour timeframe permitted under the Medicare Bridge Program, according to Vice President Tanvi Patel. Same-day delivery is now available in more than 3,100 U.S. cities and towns, expected to expand to nearly 4,500 locations by the end of 2026. The program covers Novo Nordisk's injection or pill and Eli Lilly's four-dose Zepbound KwikPen injection and Foundayo pill through the end of 2027, but not single-dose Zepbound vials or pens.

Impact on stocks 6

Biotech & Genomic Medicine▲ · 2 stocks
Eli Lilly and Company
LLY
▲ PositiveDemandrelevance

Eli Lilly's weight-loss drugs are included in Amazon's program, potentially increasing sales volume.

Novo Nordisk A/S
NOV
▲ PositiveDemandrelevance

Novo Nordisk's weight-loss drugs are covered in Amazon's program, potentially increasing sales volume.

Consumer Staples▲ · 2 stocks
Artificial Intelligence▲ · 1 stocks
Amazon.com Inc
AMZN
▲ PositiveDemandrelevance

Amazon Pharmacy expands weight-loss drug access to Medicare patients, boosting demand for its pharmacy services.

Health Care▲ · 1 stocks
© 2026 MarketDXNews